COM:CUREVAC
CureVac
- Stock
locale
Germanymarket
STOCKSindustry
Biopharmaceuticalswebsite
curevac.comcrunchbase
curevaclinkedin
curevacfounding date
Jan 01, 2000ipo date
Aug 14, 2020
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical tr...Show More